Loss of response to levodopa in Parkinson’s disease and co-occurrence with dementia: role of D3 and not D2 receptors-Reference-Cited by-同舟云学术

Loss of response to levodopa in Parkinson’s disease and co-occurrence with dementia: role of D3 and not D2 receptors

Published:2002-11 Issue:1-2 Volume:955 Page:138-152
ISSN:0006-8993
Container-title:Brain Research
language:en
Short-container-title:Brain Research

Author:

Joyce J.N,Ryoo H.L,Beach T.B,Caviness J.N,Stacy Mark,Gurevich E.V,Reiser Mark,Adler C.H

Publisher

Elsevier BV

Subject

Developmental Biology,Clinical Neurology,Molecular Biology,General Neuroscience

Reference82 articles.

1. Consensus recommendations for the postmortem diagnosis of Alzheimer’s disease, The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer’s Disease, Neurobiol. Aging 18 (1997) S1–S2.

2. Anterograde transport of brain-derived neurotrophic factor and its role in the brain;Altar;Nature,1997

3. Long-term changes of striatal dopamine D2 receptors in patients with Parkinson’s disease: a study with positron emission tomography and [11C]raclopride;Antonini;Mov. Disord.,1997

4. Complementary positron emission tomographic studies of the striatal dopaminergic system in Parkinson’s disease;Antonini;Arch. Neurol.,1995

5. Parkinson disease neuropathology: later-developing dementia and loss of the levodopa response;Apaydin;Arch. Neurol.,2002

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neurobiological and Pharmacological Perspectives of D3 Receptors in Parkinson’s Disease;Biomolecules;2022-02-01

2. Dopamine D3 Receptor in Parkinson Disease: A Prognosis Biomarker and an Intervention Target;Therapeutic Applications of Dopamine D3 Receptor Function;2022

3. Dopamine D1 + D3 receptor density may correlate with parkinson disease clinical features;Annals of Clinical and Translational Neurology;2020-12-21

4. Levodopa response in later stages of Parkinson's disease: A case-control study;Parkinsonism & Related Disorders;2020-08

5. Should We Consider Deep Brain Stimulation Discontinuation in Late‐Stage Parkinson's Disease?;Movement Disorders;2020-05-25